Assessment of pyronaridine activity in vivo and in vitro against the hepatic stages of malaria in laboratory mice

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 93, Issue 6, 1999, Pages 651-652

  Basco, Leonardo K ^a,c   Ringwald, Pascal ^a   Franetich, Jean François ^b   Mazier, Dominique ^b  

^a Inst de Rech Agric Pour Le Devmt   (Cameroon)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Organisation de Coordination pour la Lutte contre les Endemies en Afrique Centrale Cameroon   (Cameroon)

Author keywords

Drug resistance; Liver stages; Malaria; Mice; Plasmodium yoelii; Pyronaridine; Sporozoites

Indexed keywords

4 AMINOQUINOLINE; AMOPYROQUINE; CHLOROQUINE; DOXYCYCLINE; PRIMAQUINE; PROGUANIL; PYRONARIDINE;

AFRICA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RESISTANCE; ERYTHROCYTE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIFE CYCLE; LIVER; LIVER CELL; LIVER TOXICITY; MALARIA; MALARIA FALCIPARUM; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; SCHIZONT;

ANIMALIA; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII;

EID: 0033377598     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(99)90085-8     Document Type: Article

References (8)

1. Chen, C., Tang, L. H. & Jantanavivat, C. (1992). Studies on a new antimalarial compound: pyronaridine. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 7-10.
2. Childs, G. E., Hausler, B., Milhous, W., Chen, C., Wimonwattrawatee, T., Pooyindee, N. & Boudreau, E. F. (1988). In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene, 38, 24-29.
3. Looareesuwan, S., Kyle, D. E., Viravan, C., Vanijanonta, S., Wilairatana, P. & Wernsdorfer, W. H. (1996). Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 54, 205-209.
4. Mazier, D., Mellouk, S., Beaudoin, R. I., Texier, B., Druilhe, P., Hockmeyer, W., Trosper, P., Paul, C., Charoenvit, Y., Young, J., Miltgen, F., Chedid, L., Chigot, J. P., Galley, B., Brandicourt, O. & Gentilini, M. (1986). Effect of antibodies to recombinant and synthetic peptides on Plasmodium falciparum sporozoites in vitro. Science, 231, 156-159.
5. Pradines, B., Tall, A., Parzy, D., Spiegel, A., Fusai, T., Hienne, R., Trape, J. F. & Doury, J. C. (1998). In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents. Journal of Antimicrobial Chemotherapy, 42, 333-339.
6. Ringwald, P., Bickii, J. & Basco, L. (1996). Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet, 347, 24-28.
7. Ringwald, P., Bickii, J., Same-Ekobo, A. & Basco, L. K. (1997). Pyronaridine for the treatment of Plasmodium ovale and P. malariae infections. Antimicrobial Agents and Chemotherapy, 41, 2317-2319.
8. Wernsdorfer, W. H. (1997). Antimalarial drugs. In: Handbook of Malaria Infection in the Tropics, Carosi, G. & Castelli, F. (editors). Organizzazione per Ia Cooperazione Sanitaria Internazionale, Bologna, Italy, Quaderni di cooperazione sanitaria, no. 15, pp. 151-198.